BIAFW vs TDG · rev $6.2M vs P/E 41, rev $8.83B
bioAffinity Technologies Inc. Warrant (BIAFW) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
bioAffinity Technologies Inc. Warrant (BIAFW) common stock listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported BIAFW revenue for 2025-12-31 was $6.2M. Net income was -$14.9M. Revenue was down 34.2% from 2024-12-31 to 2025-12-31. BIAFW currently screens at market cap $0.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
BIAFW currently screens at market cap $0. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the BIAFW and TDG stock pages for the full models.
Not investment advice.